Company Summary
Search
Home Page
 
Hemostemix Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
December 31TradingN
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
26/Mar/2012  Canada Alberta  
Exchange Filing Office
Location
Calgary Regional Service Office
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  Consumer Products - Biotechnology/Pharmaceuticals  News Release January 12, 2015-Hemostemix is a public clinical-stage company that develops and commercializes innovative blood-derived cell therapies for medical conditions not adequately addressed by current treatments. 
Securities
SymbolSecurity NameMarketStatus
HEMHemostemix Inc.TSX VentureTRADING
Name HistoryFromTo
Hemostemix Inc.27/Nov/2014Present
Company Facts Reconciliation
SubjectDate Returned
Spring 2015 CFR Not Received
Associations
Auditing Firm:  MNP LLP
Sponsor:  Wolverton Securities Ltd.
Transfer Agent:  Computershare Trust Company of Canada
Latest Information
TypeDateTitle
News Releases  9/Oct/2018  NEWS RELEASE - THREE ADDITIONAL SITES ENROLLED IN PHASE II CLIN[MARKET NEWS]
    NEWS RELEASE - ADDITION TO CLINICAL TRIAL MANAGEMENT TEAM[MARKET NEWS]
    NEWS RELEASE - MAJOR MILESTONE ACHIEVED WITH FIRST 3 U.S. TRIAL[MARKET NEWS]
Bulletins  3/Jan/2024  PP-N-B
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data